Richter J E
Gastroenterology Division, University of Alabama School of Medicine, Birmingham.
Hosp Pract (Off Ed). 1992 Jan 15;27(1):59-66. doi: 10.1080/21548331.1992.11705342.
The pathologic potential of chronic esophagitis cannot be overemphasized. Persistent reflux causing cycles of mucosal damage followed by healing may eventually lead to end-stage disease, with development of peptic stricture. The most effective drugs available are those that inhibit acid production. Drugs that will enhance lower esophageal function are still in the future.
